semaglutide out of stock Now that shortages and tirzepatide are resolved, you may wonder if compounded GLP-1s are going away. Here's why they haven't disappeared entirely. π Check GoodRx for savings at the link FDA Warns Against Using Compounded
Description
The analogue has the same action as GLP-1

But low may do nothing
When endocrine resistance becomes the main issue In resistant HR+ disease, clinicians often look beyond a simple swap between tamoxifen and an aromatase inhibitor

This occurs because weight loss lowers estrogen levels
